$SCLL.OB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SCOLR Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SCOLR Pharma, Inc.. Get notifications about new insider transactions in SCOLR Pharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 06 2012 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | President & CEO | Option Exercise | A | 0.08 | 50,000 | 4,000 | 50,000 | |
Feb 06 2012 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | CFO & Exec. VP Fina ... | Option Exercise | A | 0.08 | 50,000 | 4,000 | 50,000 | |
Jun 20 2011 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | P | 0.05 | 50,000 | 2,500 | 1,000,000 | |
Jun 13 2011 | SCLL.OB | SCOLR Pharma, Inc. | Jeffrey Reich | Director | Option Exercise | A | 0.08 | 17,500 | 1,400 | 17,500 | |
Jun 13 2011 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 0.08 | 17,500 | 1,400 | 17,500 | |
Jun 13 2011 | SCLL.OB | SCOLR Pharma, Inc. | PINES WAYNE L | Director | Option Exercise | A | 0.08 | 17,500 | 1,400 | 17,500 | |
Jun 13 2011 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Option Exercise | A | 0.08 | 17,500 | 1,400 | 17,500 | |
Jun 13 2011 | SCLL.OB | SCOLR Pharma, Inc. | Arnett Marylou W | Director | Option Exercise | A | 0.08 | 17,500 | 1,400 | 17,500 | |
Jun 13 2011 | SCLL.OB | SCOLR Pharma, Inc. | JOHNSON CARL J | Director | Option Exercise | A | 0.08 | 250,000 | 20,000 | 250,000 | |
Jun 13 2011 | SCLL.OB | SCOLR Pharma, Inc. | JOHNSON CARL J | Director | Option Exercise | A | 0.08 | 250,000 | 20,000 | 250,000 | |
Sep 27 2010 | SCLL.OB | SCOLR Pharma, Inc. | JOHNSON CARL J | Director | Option Exercise | A | 0.64 | 250,000 | 160,000 | 250,000 | |
Jun 11 2010 | SCLL.OB | SCOLR Pharma, Inc. | Jeffrey Reich | Director | Option Exercise | A | 0.45 | 17,500 | 7,875 | 17,500 | |
Jun 11 2010 | SCLL.OB | SCOLR Pharma, Inc. | PINES WAYNE L | Director | Option Exercise | A | 0.45 | 17,500 | 7,875 | 17,500 | |
Jun 11 2010 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 0.45 | 22,500 | 10,125 | 22,500 | |
Jun 11 2010 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Option Exercise | A | 0.45 | 17,500 | 7,875 | 17,500 | |
Jun 11 2010 | SCLL.OB | SCOLR Pharma, Inc. | JOHNSON CARL J | Director | Option Exercise | A | 0.45 | 32,500 | 14,625 | 32,500 | |
Jun 11 2010 | SCLL.OB | SCOLR Pharma, Inc. | JOHNSON CARL J | Director | Option Exercise | A | 0.45 | 17,500 | 7,875 | 17,500 | |
Jun 11 2010 | SCLL.OB | SCOLR Pharma, Inc. | Arnett Marylou W | Director | Option Exercise | A | 0.45 | 32,500 | 14,625 | 32,500 | |
Jun 11 2010 | SCLL.OB | SCOLR Pharma, Inc. | Arnett Marylou W | Director | Option Exercise | A | 0.45 | 17,500 | 7,875 | 17,500 | |
Jan 06 2010 | SCLL.OB | SCOLR Pharma, Inc. | MORRA BRUCE S | Director | Grant | A | 0.00 | 214,285 | 0 | 214,285 | 0 to 214.3 K |
Oct 29 2009 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Option Exercise | A | 0.48 | 500,000 | 240,000 | 500,000 | |
Oct 29 2009 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | President & CEO | Option Exercise | A | 0.48 | 500,000 | 240,000 | 500,000 | |
Oct 29 2009 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Lega ... | Option Exercise | A | 0.48 | 200,000 | 96,000 | 200,000 | |
Jun 15 2009 | SCLL.OB | SCOLR Pharma, Inc. | CAUDILL RANDALL L W | Director | Option Exercise | A | 0.39 | 17,500 | 6,825 | 17,500 | |
Jun 15 2009 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Option Exercise | A | 0.39 | 17,500 | 6,825 | 17,500 | |
Jun 15 2009 | SCLL.OB | SCOLR Pharma, Inc. | PINES WAYNE L | Director | Option Exercise | A | 0.39 | 17,500 | 6,825 | 17,500 | |
Jun 15 2009 | SCLL.OB | SCOLR Pharma, Inc. | Jeffrey Reich | Director | Option Exercise | A | 0.39 | 17,500 | 6,825 | 17,500 | |
Jun 15 2009 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 0.39 | 22,500 | 8,775 | 22,500 | |
Mar 19 2009 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Buy | P | 0.25 | 2,500 | 625 | 440,785 | 438.3 K to 440.8 K (+0.57 %) |
Feb 03 2009 | SCLL.OB | SCOLR Pharma, Inc. | MORRA BRUCE S | Chief Executive Off ... | Option Exercise | A | 0.66 | 500,000 | 330,000 | 500,000 | |
Dec 08 2008 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Option Exercise | A | 0.81 | 77,792 | 63,012 | 77,792 | |
Dec 08 2008 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | Chief Technology Of ... | Option Exercise | A | 0.81 | 86,706 | 70,232 | 86,706 | |
Dec 08 2008 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Lega ... | Option Exercise | A | 0.81 | 115,397 | 93,472 | 115,397 | |
Nov 19 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 0.98 | 200 | 196 | 109,000 | 108.8 K to 109 K (+0.18 %) |
Nov 19 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 0.95 | 1,900 | 1,805 | 108,800 | 106.9 K to 108.8 K (+1.78 %) |
Nov 19 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 0.91 | 500 | 455 | 106,900 | 106.4 K to 106.9 K (+0.47 %) |
Nov 19 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 0.90 | 500 | 450 | 106,400 | 105.9 K to 106.4 K (+0.47 %) |
Nov 19 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 0.87 | 100 | 87 | 105,900 | 105.8 K to 105.9 K (+0.09 %) |
Nov 19 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 0.85 | 1,500 | 1,275 | 105,800 | 104.3 K to 105.8 K (+1.44 %) |
Nov 19 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 0.84 | 300 | 252 | 104,300 | 104 K to 104.3 K (+0.29 %) |
Nov 13 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 0.89 | 5,000 | 4,450 | 104,000 | 99 K to 104 K (+5.05 %) |
Nov 13 2008 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Lega ... | Buy | P | 0.89 | 3,000 | 2,670 | 33,000 | 30 K to 33 K (+10.00 %) |
Nov 12 2008 | SCLL.OB | SCOLR Pharma, Inc. | Jeffrey Reich | Director | Buy | P | 0.94 | 8,800 | 8,272 | 25,000 | 16.2 K to 25 K (+54.32 %) |
Nov 12 2008 | SCLL.OB | SCOLR Pharma, Inc. | Jeffrey Reich | Director | Buy | P | 0.93 | 11,700 | 10,881 | 16,200 | 4.5 K to 16.2 K (+260.00 %) |
Nov 12 2008 | SCLL.OB | SCOLR Pharma, Inc. | Jeffrey Reich | Director | Buy | P | 0.92 | 100 | 92 | 4,500 | 4.4 K to 4.5 K (+2.27 %) |
Nov 12 2008 | SCLL.OB | SCOLR Pharma, Inc. | Jeffrey Reich | Director | Buy | P | 0.91 | 100 | 91 | 4,400 | 4.3 K to 4.4 K (+2.33 %) |
Nov 12 2008 | SCLL.OB | SCOLR Pharma, Inc. | Jeffrey Reich | Director | Buy | P | 0.90 | 4,300 | 3,870 | 4,300 | 0 to 4.3 K |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | WEAVER GREGORY L | Director | Option Exercise | A | 1.17 | 17,500 | 20,475 | 17,500 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Option Exercise | A | 1.17 | 93,000 | 108,810 | 93,000 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | Jeffrey Reich | Director | Option Exercise | A | 1.17 | 17,500 | 20,475 | 17,500 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | PINES WAYNE L | Director | Option Exercise | A | 1.17 | 17,500 | 20,475 | 17,500 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | MORRA BRUCE S | Director | Option Exercise | A | 1.17 | 17,500 | 20,475 | 17,500 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Option Exercise | A | 1.17 | 17,500 | 20,475 | 17,500 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Option Exercise | A | 1.17 | 17,500 | 20,475 | 17,500 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | CAUDILL RANDALL L W | Director | Option Exercise | A | 1.17 | 17,500 | 20,475 | 17,500 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 1.17 | 22,500 | 26,325 | 22,500 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | Chief Technology Of ... | Option Exercise | A | 1.17 | 104,000 | 121,680 | 104,000 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Option Exercise | A | 1.17 | 100,000 | 117,000 | 100,000 | |
Jun 06 2008 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Lega ... | Option Exercise | A | 1.17 | 122,000 | 142,740 | 122,000 | |
Jun 02 2008 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 1.09 | 1,500 | 1,635 | 27,600 | 26.1 K to 27.6 K (+5.75 %) |
Jun 02 2008 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 1.10 | 3,500 | 3,850 | 26,100 | 22.6 K to 26.1 K (+15.49 %) |
May 30 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 1.05 | 800 | 840 | 99,000 | 98.2 K to 99 K (+0.81 %) |
May 30 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 1.04 | 1,700 | 1,768 | 98,200 | 96.5 K to 98.2 K (+1.76 %) |
May 08 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 1.07 | 1,400 | 1,498 | 96,500 | 95.1 K to 96.5 K (+1.47 %) |
May 08 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 1.06 | 1,100 | 1,166 | 95,400 | 94.3 K to 95.4 K (+1.17 %) |
Mar 13 2008 | SCLL.OB | SCOLR Pharma, Inc. | CAUDILL RANDALL L W | Director | Option Exercise | X | 1.00 | 50,000 | 50,000 | 0 | |
Mar 13 2008 | SCLL.OB | SCOLR Pharma, Inc. | CAUDILL RANDALL L W | Director | Sell | S | 1.00 | 39,526 | 39,526 | 10,474 | 50 K to 10.5 K (-79.05 %) |
Mar 13 2008 | SCLL.OB | SCOLR Pharma, Inc. | CAUDILL RANDALL L W | Director | Buy | X | 1.00 | 50,000 | 50,000 | 50,000 | 0 to 50 K |
Feb 13 2008 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | Chief Technology Of ... | Grant | A | 0.00 | 9,500 | 0 | 26,500 | 17 K to 26.5 K (+55.88 %) |
Feb 13 2008 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Grant | A | 0.00 | 32,000 | 0 | 94,000 | 62 K to 94 K (+51.61 %) |
Feb 13 2008 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Grant | A | 0.00 | 17,000 | 0 | 17,000 | 0 to 17 K |
Feb 13 2008 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Lega ... | Grant | A | 0.00 | 20,000 | 0 | 30,000 | 10 K to 30 K (+200.00 %) |
Jan 25 2008 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Option Exercise | M | 1.00 | 20,000 | 20,000 | 0 | |
Jan 25 2008 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Buy | M | 1.00 | 20,000 | 20,000 | 712,396 | 692.4 K to 712.4 K (+2.89 %) |
Dec 18 2007 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | Chief Technology Of ... | Option Exercise | M | 0.56 | 10,000 | 5,600 | 15,000 | |
Dec 18 2007 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | Chief Technology Of ... | Buy | M | 0.56 | 10,000 | 5,600 | 17,000 | 7 K to 17 K (+142.86 %) |
Dec 12 2007 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | Chief Technology Of ... | Option Exercise | A | 1.25 | 30,000 | 37,500 | 30,000 | |
Dec 12 2007 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Lega ... | Option Exercise | A | 1.25 | 65,000 | 81,250 | 65,000 | |
Dec 12 2007 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Option Exercise | A | 1.25 | 100,000 | 125,000 | 100,000 | |
Dec 12 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Option Exercise | A | 1.25 | 55,000 | 68,750 | 55,000 | |
Dec 12 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 1.21 | 2,000 | 2,420 | 22,600 | 20.6 K to 22.6 K (+9.71 %) |
Dec 12 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 1.25 | 2,000 | 2,500 | 20,600 | 18.6 K to 20.6 K (+10.75 %) |
Dec 10 2007 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Leg ... | Buy | P | 1.24 | 616 | 764 | 10,000 | 9.4 K to 10 K (+6.56 %) |
Dec 10 2007 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Leg ... | Buy | P | 1.23 | 2,500 | 3,075 | 9,384 | 6.9 K to 9.4 K (+36.32 %) |
Dec 10 2007 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Leg ... | Buy | P | 1.30 | 384 | 499 | 6,884 | 6.5 K to 6.9 K (+5.91 %) |
Dec 10 2007 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Leg ... | Buy | P | 1.31 | 1,000 | 1,310 | 6,500 | 5.5 K to 6.5 K (+18.18 %) |
Dec 10 2007 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Sr. VP - Chief Leg ... | Buy | P | 1.32 | 3,000 | 3,960 | 5,500 | 2.5 K to 5.5 K (+120.00 %) |
Dec 07 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 1.34 | 2,000 | 2,680 | 18,600 | 16.6 K to 18.6 K (+12.05 %) |
Dec 07 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 1.34 | 2,000 | 2,680 | 16,600 | 14.6 K to 16.6 K (+13.70 %) |
Dec 07 2007 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Buy | P | 1.32 | 10,000 | 13,200 | 438,285 | 428.3 K to 438.3 K (+2.33 %) |
Dec 06 2007 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 1.34 | 5,800 | 7,772 | 62,000 | 56.2 K to 62 K (+10.32 %) |
Dec 06 2007 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Chief Executive Off ... | Buy | P | 1.35 | 4,200 | 5,670 | 56,200 | 52 K to 56.2 K (+8.08 %) |
Oct 10 2007 | SCLL.OB | SCOLR Pharma, Inc. | Jeffrey Reich | Director | Option Exercise | A | 3.18 | 44,167 | 140,451 | 44,167 | |
Oct 10 2007 | SCLL.OB | SCOLR Pharma, Inc. | WEAVER GREGORY L | Director | Option Exercise | A | 3.18 | 44,167 | 140,451 | 44,167 | |
Aug 14 2007 | SCLL.OB | SCOLR Pharma, Inc. | MORRA BRUCE S | Director | Option Exercise | A | 2.29 | 47,083 | 107,820 | 47,083 | |
Jun 08 2007 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Option Exercise | A | 2.31 | 17,500 | 40,425 | 17,500 | |
Jun 08 2007 | SCLL.OB | SCOLR Pharma, Inc. | CAUDILL RANDALL L W | Director | Option Exercise | A | 2.31 | 17,500 | 40,425 | 17,500 | |
Jun 08 2007 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Option Exercise | A | 2.31 | 17,500 | 40,425 | 17,500 | |
Jun 08 2007 | SCLL.OB | SCOLR Pharma, Inc. | PINES WAYNE L | Director | Option Exercise | A | 2.31 | 17,500 | 40,425 | 17,500 | |
May 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Director | Buy | P | 2.42 | 2,200 | 5,324 | 52,000 | 49.8 K to 52 K (+4.42 %) |
May 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Director | Buy | P | 2.41 | 1,200 | 2,892 | 49,800 | 48.6 K to 49.8 K (+2.47 %) |
May 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Director | Buy | P | 2.40 | 1,400 | 3,360 | 48,600 | 47.2 K to 48.6 K (+2.97 %) |
May 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Director | Buy | P | 2.38 | 200 | 476 | 47,200 | 47 K to 47.2 K (+0.43 %) |
Jun 08 2007 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 2.31 | 22,500 | 51,975 | 22,500 | |
Mar 21 2007 | SCLL.OB | SCOLR Pharma, Inc. | MITCHEL ALAN M | Chief Legal Officer | Buy | P | 2.40 | 2,500 | 6,000 | 2,500 | 0 to 2.5 K |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Buy | P | 2.32 | 30,000 | 69,600 | 428,285 | 398.3 K to 428.3 K (+7.53 %) |
Mar 19 2007 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Option Exercise | M | 0.32 | 20,000 | 6,400 | 0 | |
Mar 19 2007 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Buy | M | 0.32 | 20,000 | 6,400 | 692,396 | 672.4 K to 692.4 K (+2.97 %) |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | V.P., Chief Technic ... | Option Exercise | M | 0.66 | 2,000 | 1,320 | 23,000 | |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | V.P., Chief Technic ... | Option Exercise | M | 0.35 | 5,000 | 1,750 | 0 | |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | V.P., Chief Technic ... | Buy | M | 0.66 | 2,000 | 1,320 | 7,000 | 5 K to 7 K (+40.00 %) |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | TURNER STEPHEN | V.P., Chief Technic ... | Buy | M | 0.35 | 5,000 | 1,750 | 5,000 | 0 to 5 K |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Director | Buy | P | 2.25 | 7,300 | 16,425 | 47,000 | 39.7 K to 47 K (+18.39 %) |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Director | Buy | P | 2.24 | 500 | 1,120 | 39,700 | 39.2 K to 39.7 K (+1.28 %) |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | Director | Buy | P | 2.23 | 2,200 | 4,906 | 39,200 | 37 K to 39.2 K (+5.95 %) |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 2.20 | 40 | 88 | 14,600 | 14.6 K to 14.6 K (+0.27 %) |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 2.23 | 100 | 223 | 14,560 | 14.5 K to 14.6 K (+0.69 %) |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 2.23 | 100 | 223 | 14,460 | 14.4 K to 14.5 K (+0.70 %) |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 2.23 | 100 | 223 | 14,360 | 14.3 K to 14.4 K (+0.70 %) |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 2.24 | 5,060 | 11,334 | 14,260 | 9.2 K to 14.3 K (+55.00 %) |
Mar 16 2007 | SCLL.OB | SCOLR Pharma, Inc. | LEVY RICHARD M | Chief Financial Off ... | Buy | P | 2.25 | 9,200 | 20,700 | 9,200 | 0 to 9.2 K |
Feb 22 2007 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 7.50 | 5,500 | 41,250 | 0 | |
Feb 22 2007 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 7.50 | 5,500 | 41,250 | 5,500 | |
Feb 06 2007 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Option Exercise | M | 1.05 | 50,000 | 52,500 | 0 | |
Feb 06 2007 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Buy | M | 1.05 | 50,000 | 52,500 | 50,067 | 67 to 50.1 K (+74,626.87 %) |
Nov 14 2006 | SCLL.OB | SCOLR Pharma, Inc. | TAGLICH MICHAEL N | Director | Buy | P | 4.90 | 5,000 | 24,500 | 398,285 | 393.3 K to 398.3 K (+1.27 %) |
Nov 13 2006 | SCLL.OB | SCOLR Pharma, Inc. | WILDS DANIEL O | President and CEO | Buy | P | 4.77 | 5,000 | 23,850 | 37,000 | 32 K to 37 K (+15.63 %) |
Nov 08 2006 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Option Exercise | M | 0.80 | 15,000 | 12,000 | 0 | |
Nov 08 2006 | SCLL.OB | SCOLR Pharma, Inc. | LUCAS HERBERT L JR | Director | Buy | M | 0.80 | 15,000 | 12,000 | 672,396 | 657.4 K to 672.4 K (+2.28 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.97 | 4,000 | 19,880 | 67 | 4.1 K to 67 (-98.35 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.89 | 2,000 | 9,780 | 4,067 | 6.1 K to 4.1 K (-32.97 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.88 | 2,600 | 12,688 | 6,067 | 8.7 K to 6.1 K (-30.00 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.87 | 11,400 | 55,518 | 8,667 | 20.1 K to 8.7 K (-56.81 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.86 | 500 | 2,430 | 20,067 | 20.6 K to 20.1 K (-2.43 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.85 | 3,100 | 15,035 | 20,567 | 23.7 K to 20.6 K (-13.10 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.83 | 600 | 2,898 | 23,667 | 24.3 K to 23.7 K (-2.47 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.82 | 100 | 482 | 24,267 | 24.4 K to 24.3 K (-0.41 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.81 | 1,000 | 4,810 | 24,367 | 25.4 K to 24.4 K (-3.94 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.80 | 5,100 | 24,480 | 25,367 | 30.5 K to 25.4 K (-16.74 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.79 | 3,100 | 14,849 | 30,467 | 33.6 K to 30.5 K (-9.24 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.73 | 500 | 2,365 | 33,567 | 34.1 K to 33.6 K (-1.47 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.82 | 500 | 2,410 | 34,067 | 34.6 K to 34.1 K (-1.45 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.81 | 800 | 3,848 | 34,567 | 35.4 K to 34.6 K (-2.26 %) |
Aug 29 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.80 | 2,700 | 12,960 | 35,367 | 38.1 K to 35.4 K (-7.09 %) |
Aug 28 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.87 | 300 | 1,461 | 38,067 | 38.4 K to 38.1 K (-0.78 %) |
Aug 28 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.86 | 200 | 972 | 38,367 | 38.6 K to 38.4 K (-0.52 %) |
Aug 28 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.85 | 3,000 | 14,550 | 38,567 | 41.6 K to 38.6 K (-7.22 %) |
Aug 28 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.83 | 500 | 2,415 | 41,567 | 42.1 K to 41.6 K (-1.19 %) |
Aug 28 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.95 | 1,700 | 8,415 | 42,067 | 43.8 K to 42.1 K (-3.88 %) |
Aug 28 2006 | SCLL.OB | SCOLR Pharma, Inc. | FASSIHI REZA | Director | Sell | S | 4.94 | 500 | 2,470 | 43,767 | 44.3 K to 43.8 K (-1.13 %) |